{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:17Z","timestamp":1791078857241,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jaad.2003.10.669","type":"journal-article","created":{"date-parts":[[2004,2,26]],"date-time":"2004-02-26T08:25:52Z","timestamp":1077783952000},"page":"375-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms"],"prefix":"10.1016","volume":"50","author":[{"given":"Karen S","family":"McGinnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M","family":"Junkins-Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela C","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2003.10.669_BIB1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2133.1988.tb02600.x","article-title":"Treatment of mycosis fungoides with recombinant interferon-alpha-2a alone and in combination with etretinate","volume":"118","author":"Thestrup-Pedersen","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09546638909086685","article-title":"Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alfa-2a","volume":"1","author":"Braathen","year":"1989","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2003.10.669_BIB3","doi-asserted-by":"crossref","unstructured":"Knobler RM, Trautinger F, Radaszkiewicz T, Kokoschka EM, Micksche M. Treatment of cutaneous T-cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 1991;24:247-52","DOI":"10.1016\/0190-9622(91)70036-2"},{"key":"10.1016\/j.jaad.2003.10.669_BIB4","doi-asserted-by":"crossref","unstructured":"Dreno B, Claudy A, Meynadier J, Verret JL, Souteyrand P, Ortonne JP, et al. The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alfa 2a and etretinate. Br J Dermatol 1991;125:456-9","DOI":"10.1111\/j.1365-2133.1991.tb14772.x"},{"key":"10.1016\/j.jaad.2003.10.669_BIB5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1993.tb01458.x","article-title":"Intramuscular low dose alpha-2b interferon and etretinate for treatment of mycosis fungoides","volume":"32","author":"Altomare","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/stem.5530110403","article-title":"Roferon A (interferon alpha 2a) combined with Tigison (etretinate) for treatment of cutaneous T cell lymphomas","volume":"11","author":"Dreno","year":"1993","journal-title":"Stem Cells"},{"key":"10.1016\/j.jaad.2003.10.669_BIB7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1346-8138.1994.tb03285.x","article-title":"Interferon-alpha (IFN-alpha) and etretinate in the treatment of mycosis fungoides","volume":"21","author":"Torii","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB8","unstructured":"Stadler R, Otte HG, Luger T, Henz BM, Kuhl P, Zwingers T, et al. Prospective randomized multicenter clinical trial on the use of interferon alpha-2a plus acitretin versus interferon alpha-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998;92:3578-81"},{"key":"10.1016\/j.jaad.2003.10.669_BIB9","unstructured":"Duvic M, Martin A, Kim Y, Olsen E, Wood GS, Crowley CA, et al. Phase 2 and 3 clinical trial for oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 2001;137:581-93"},{"key":"10.1016\/j.jaad.2003.10.669_BIB10","doi-asserted-by":"crossref","unstructured":"Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 2001;19:2456-71","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"10.1016\/j.jaad.2003.10.669_BIB11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/mjd.2002.124607","article-title":"Optimizing bexarotene therapy for cutaneous T-cell lymphoma","volume":"47","author":"Talpur","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB12","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2003.10.669_BIB13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0889-8588(18)30055-8","article-title":"Prognosis and staging of cutaneous T cell lymphoma","volume":"9","author":"Foss","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2003.10.669_BIB14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB16","doi-asserted-by":"crossref","unstructured":"Fox FE, Kubin M, Cassin M, Niu Z, Trinchieri G, Cooper KD, et al. Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Cytokine Res 1999;19:407-15","DOI":"10.1089\/107999099314117"},{"key":"10.1016\/j.jaad.2003.10.669_BIB17","doi-asserted-by":"crossref","unstructured":"Suchin KR, Cassin M, Gottleib SL, Sood S, Cucchiara AJ, Vonderheid EC, et al. Increased interleukin 5 production in eosinophilic S\u00e9zary syndrome: regulation by interferon alfa and interleukin 12. J Am Acad Dermatol 2001;44:28-32","DOI":"10.1067\/mjd.2001.109853"},{"key":"10.1016\/j.jaad.2003.10.669_BIB18","first-page":"55","article-title":"Stimulatory effects of vitamin A analogues on induction of cell mediated cytotoxicity in vivo","volume":"39","author":"Lotan","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2003.10.669_BIB19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/eji.1830080106","article-title":"Effects of retinoic acid on the immune system","volume":"8","author":"Denert","year":"1978","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0008-8749(82)90208-8","article-title":"Effect of recombinant interferon on cytotoxic activity of NK cells and monocytes","volume":"67","author":"Herberman","year":"1982","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4049\/jimmunol.126.6.2129","article-title":"Natural killer cell reactivity","volume":"126","author":"Goldfarb","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB22","first-page":"3158","article-title":"Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells","volume":"55","author":"Lancillotti","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2003.10.669_BIB23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.2910570115","article-title":"Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis","volume":"57","author":"Majewki","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2003.10.669_BIB24","first-page":"649","article-title":"A new rexinoid for cutaneous T-cell lymphoma","volume":"137","author":"Cheng","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/330624a0","article-title":"Identification of a receptor for the morphogen retinoic acid","volume":"330","author":"Giguere","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2003.10.669_BIB26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/330444a0","article-title":"A human retinoic acid receptor which belongs to the family of nuclear receptors","volume":"330","author":"Petkovich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2003.10.669_BIB27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/345224a0","article-title":"A nuclear receptor that identifies a novel retinoic acid response pathway","volume":"345","author":"Mangelsdorf","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2003.10.669_BIB28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jaad.2003.10.669_BIB29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0753-3322(91)90102-Y","article-title":"Nuclear receptors for retinoids","volume":"45","author":"Lotan","year":"1991","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaad.2003.10.669_BIB30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","article-title":"The RXR heterodimers and orphan receptors","volume":"83","author":"Manglesdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2003.10.669_BIB31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.cdd.4400313","article-title":"Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors","volume":"5","author":"Szonday","year":"1998","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaad.2003.10.669_BIB32","doi-asserted-by":"crossref","unstructured":"Komuves LG, Hanley K, Lefebvre A-M, Man MQ, Ng DC, Bikle DD, et al. Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 2000;115:353-60","DOI":"10.1046\/j.1523-1747.2000.00073.x"},{"key":"10.1016\/j.jaad.2003.10.669_BIB33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1523-1747.2000.00076.x","article-title":"Keratinocyte differentiation in hyperproliferative epidermis","volume":"115","author":"Komuves","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB34","doi-asserted-by":"crossref","unstructured":"Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD, et al. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPAR alpha. J Invest Dermatol 1998;110:368-75","DOI":"10.1046\/j.1523-1747.1998.00139.x"},{"key":"10.1016\/j.jaad.2003.10.669_BIB35","doi-asserted-by":"crossref","unstructured":"Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, et al. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist. J Biol Chem 2000;275:4541-4","DOI":"10.1074\/jbc.275.7.4541"},{"key":"10.1016\/j.jaad.2003.10.669_BIB36","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2003.10.669_BIB37","doi-asserted-by":"crossref","unstructured":"Nawa T, Nawa MT, Cai T, Zhang C, Uchimura I, Narumi S, et al. Repression of TNF-alpha-induced E-selectin expression by PPAR activators: involvement of transcriptional repressor LRF-1\/ATF3. Biochem Biophys Res Commun 2000;275:406-11","DOI":"10.1006\/bbrc.2000.3332"},{"key":"10.1016\/j.jaad.2003.10.669_BIB38","doi-asserted-by":"crossref","unstructured":"Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, et al. Peroxisome proliferator-activated receptor gamma activators inhibit IFN gamma-induced expression of the T cell active CXC chemokines IP-10, Mig and I-TAC in human endothelial cells. J Immunol 2000;164:6503-8","DOI":"10.4049\/jimmunol.164.12.6503"},{"key":"10.1016\/j.jaad.2003.10.669_BIB39","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells","volume":"8","author":"Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2003.10.669_BIB40","doi-asserted-by":"crossref","unstructured":"Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M, et al. Critical roles of PPAR beta\/delta in keratinocyte response to inflammation. Genes Dev 2001;15:3263-77","DOI":"10.1101\/gad.207501"},{"key":"10.1016\/j.jaad.2003.10.669_BIB41","doi-asserted-by":"crossref","unstructured":"Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, et al. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998;273:25573-80","DOI":"10.1074\/jbc.273.40.25573"},{"key":"10.1016\/j.jaad.2003.10.669_BIB42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02684000","article-title":"Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes","volume":"51","author":"Grip","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaad.2003.10.669_BIB43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/phrs.2001.0922","article-title":"Modulation of inflammatory mediators and PPAR-gamma and NF-kappa-B expression by pravastatin in response to lipoproteins in human monocytes in vitro","volume":"45","author":"Zelvyte","year":"2002","journal-title":"Pharmacol Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203042762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203042762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:27:39Z","timestamp":1759267659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203042762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0190962203042762"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2003.10.669","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2003.10.669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}